InvestorsHub Logo
Followers 276
Posts 32701
Boards Moderated 0
Alias Born 11/14/2013

Re: Astavakra post# 3736

Monday, 01/27/2014 5:59:26 PM

Monday, January 27, 2014 5:59:26 PM

Post# of 700553
To me, its pretty clear from today's pre-announcement, NWBO restricted themselves to Direct.

….Today that Dr. Marnix Bosch, Chief Technical Officer of NW Bio, will make a presentation concerning NW Bio's DCVax-Direct Phase I/II Trial for inoperable solid tumor cancers at Phacilitate's Washington BioLeaders Immunotherapy 2014 Forum in Washington, DC on Monday, January 27, 2014. Dr. Bosch will describe the DCVax-Direct technology and clinical trial program.

[Emphasis Added]

Again, I think this was appropriate, given the outstanding and imminent 1st interim analysis DMC recommendation. Best to avoid any confusion.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News